Atrium Therapeutics Reports Second Quarter 2026 Financial Results

Go back to Atrium Therapeutics Reports Second Quarter 2026 Financial Results
PROSENSA HOLD (NASDAQ: RNA) Delayed: 12.33 --0 (-0%)
Previous Close $12.33    52 Week High $22.80 
Open $12.33    52 Week Low $4.12 
Day High $12.33    P/E N/A 
Day Low $12.33    EPS $0.00 
Volume 40       

PROSENSA HOLD (NASDAQ: RNA) Delayed: 12.33 --0 (-0%)
Previous Close $12.33    52 Week High $22.80 
Open $12.33    52 Week Low $4.12 
Day High $12.33    P/E N/A 
Day Low $12.33    EPS $0.00 
Volume 40